Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal for Immunotherapy of Cancer|November 29, 2016
Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptideIoannis F Voutsas, Eleftheria A Anastasopoulou, Panagiotis Tzonis, et al.
International Journal of Molecular Sciences|March 29, 2023
Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate CancerMaria Goulielmaki, Savvas Stokidis, Theodoros Anagnostou, et al.
Cancer Immunology, Immunotherapy : CII|September 6, 2017
Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical modelSotirios P Fortis, Louisa G Mahaira, Eleftheria A Anastasopoulou, et al.
Current Drug Targets|July 16, 2014
New use for old drugs? Prospective targets of chloroquines in cancer therapySpiros Vlahopoulos, Elena Critselis, Ioannis F Voutsas, et al.
Anticancer Research|December 25, 2016
Potential Prognostic Molecular Signatures in a Preclinical Model of MelanomaSotirios P Fortis, Eleftheria A Anastasopoulou, Ioannis F Voutsas, et al.
Journal of Immunological Methods|June 22, 2007
A novel quantitative flow cytometric method for measuring glucocorticoid receptor (GR) in cell lines: correlation with the biochemical determination of GRIoannis F Voutsas, Angelos D Gritzapis, Michael N Alexis, et al.
Cancers|June 10, 2022
T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy BiomarkerConstantin N Baxevanis, Angelos D Gritzapis, Ioannis F Voutsas, et al.
International Journal of Cancer|July 20, 2007
Induction of potent CD4+ T cell-mediated antitumor responses by a helper HER-2/neu peptide linked to the Ii-Key moiety of the invariant chainIoannis F Voutsas, Angelos D Gritzapis, Louisa G Mahaira, et al.
Oncology|March 1, 2013
Chemotherapy ± cetuximab modulates peripheral immune responses in metastatic colorectal cancerIoannis D Xynos, Maria L Karadima, Ioannis F Voutsas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Identification of a novel immunogenic HLA-A*0201-binding epitope of HER-2/neu with potent antitumor propertiesAngelos D Gritzapis, Ioannis F Voutsas, Eftychia Lekka, et al.
Pageof 3